Increased bone marrow SUVmax on 18F-FDG PET is associated with higher pelvic treatment failure in patients with cervical cancer treated by chemoradiotherapy and brachytherapy

The aim of this study was to evaluate if bone marrow (BM) SUVmax measured on pre-treatment 18F-FDG PET/CT predicts the clinical outcome of locally advanced cervical cancer (LACC). We recruited retrospectively patients with LACC who underwent staging 18F-FDG PET/CT and had baseline blood tests, then...

Descripción completa

Detalles Bibliográficos
Autores principales: Seban, Romain-David, Robert, Charlotte, Dercle, Laurent, Yeh, Randy, Dunant, Ariane, Reuze, Sylvain, Schernberg, Antoine, Sun, Roger, Mignot, Fabien, Terroir, Marie, Schlumberger, Martin, Haie-Meder, Christine, Chargari, Cyrus, Deutsch, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6492982/
https://www.ncbi.nlm.nih.gov/pubmed/31069132
http://dx.doi.org/10.1080/2162402X.2019.1574197

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6492982/
https://www.ncbi.nlm.nih.gov/pubmed/31069132
http://dx.doi.org/10.1080/2162402X.2019.1574197

Ejemplares similares